Trial Profile
A retrospective study assessing the incidence of renal cyst formation, risk factors for cyst formation and a radiological description of cyst characteristics in patients treated with crizotinib for non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 12 Jan 2018 New trial record